Researchers at MIT and Harvard University have designed a way to selectively turn on gene therapies in target cells, including human cells. Their technology can detect specific messenger RNA sequences in cells, and that detection then triggers production of a specific protein from a transgene, or artificial gene.
Click here for original story, Engineers devise a way to selectively turn on RNA therapies in human cells
Source: Phys.org